Caspofungin Acetate, Fluconazole, or Voriconazole in Preventing Fungal Infections in Patients Following Donor Stem Cell Transplant

This randomized phase III trial studies how well caspofungin acetate works compared to
fluconazole or voriconazole in preventing fungal infections in patients following donor stem
cell transplant. Caspofungin acetate, fluconazole, and voriconazole may be effective in
preventing fungal infections in patients following donor stem cell transplant. It is not yet
known whether caspofungin acetate is more effective than fluconazole or voriconazole in
preventing fungal infections in patients following donor stem cell transplant.

Intervention

Caspofungin Acetate, Fluconazole, Laboratory Biomarker Analysis, Voriconazole

Condition

Fungal Infection, Hematopoietic and Lymphoid Cell Neoplasm

Investigators

Christopher C Dvorak

See list of participating sites